Non-founder BRCA1 mutations in Russian breast cancer patients.

[1]  A. Sokolenko,et al.  Mixed epithelial/mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast in BRCA1 carrier , 2011, Breast cancer.

[2]  A. Sokolenko,et al.  High sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases. , 2010, Cancer genetics and cytogenetics.

[3]  M. Tejada,et al.  LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not , 2010, Familial Cancer.

[4]  A. Ashworth,et al.  Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. , 2009, The New England journal of medicine.

[5]  E. Bakker,et al.  Diagnostic guidelines for high‐resolution melting curve (HRM) analysis: An interlaboratory validation of BRCA1 mutation scanning using the 96‐well LightScanner™ , 2009, Human mutation.

[6]  J. Kładny,et al.  Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients , 2009, Breast Cancer Research and Treatment.

[7]  P. Devilee,et al.  A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history , 2009, Breast Cancer Research.

[8]  T. Dörk,et al.  Nijmegen Breakage Syndrome mutations and risk of breast cancer , 2008, International journal of cancer.

[9]  L. Shulman,et al.  A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition Genes , 2008 .

[10]  Å. Borg,et al.  BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. , 2008, Oncology reports.

[11]  Olufunmilayo I. Olopade,et al.  Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations , 2007, Nature Reviews Cancer.

[12]  R. Schmutzler,et al.  Association of the BRCA1 missense variant R1699W with a malignant phyllodes tumor of the breast. , 2007, Cancer genetics and cytogenetics.

[13]  S. Tjulandin,et al.  High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer , 2007, Bulletin of Experimental Biology and Medicine.

[14]  R. Mariani-Costantini,et al.  High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  S. Cascio,et al.  Founder mutations in BRCA1 and BRCA2 genes. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  M. Carey,et al.  Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series , 2007, International Journal of Gynecologic Cancer.

[17]  Funda Meric-Bernstam,et al.  Heterogenic Loss of BRCA in Breast Cancer: The “Two-Hit” Hypothesis Takes a Hit , 2007, Annals of Surgical Oncology.

[18]  P. Devilee,et al.  Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia , 2007, Familial Cancer.

[19]  Andrej Sali,et al.  Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. , 2007, Cancer research.

[20]  Tom Walsh,et al.  Ten genes for inherited breast cancer. , 2007, Cancer cell.

[21]  W. Han,et al.  BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. , 2007, Cancer letters.

[22]  J. Damborský,et al.  High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic , 2007, BMC Medical Genetics.

[23]  U. Hamann,et al.  Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients , 2006, International journal of cancer.

[24]  P. Devilee,et al.  High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. , 2006, European journal of cancer.

[25]  P. Devilee,et al.  CHEK2 1100delC mutation is frequent among Russian breast cancer patients , 2006, Breast Cancer Research and Treatment.

[26]  S. Hodgson,et al.  Low Prevalence of BRCA1 Exon Rearrangements in Familial and Young Sporadic Breast Cancer Patients , 2006, Familial Cancer.

[27]  L. Esserman,et al.  Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. , 2005, JAMA.

[28]  T. Dörk,et al.  Association of two mutations in the CHEK2 gene with breast cancer , 2005, International journal of cancer.

[29]  A. Jakubowska,et al.  Breast cancer predisposing alleles in Poland , 2005, Breast Cancer Research and Treatment.

[30]  P. Devilee,et al.  NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia , 2005, International journal of cancer.

[31]  V. Vasilyev,et al.  Prevalence of widespread BRCA1 gene mutations in patients with familial breast cancer from St. Petersburg , 2005, Russian Journal of Genetics.

[32]  C. Bartram,et al.  Large BRCA1 gene deletions are found in 3% of German high‐risk breast cancer families , 2004, Human mutation.

[33]  A. Zharkikh,et al.  Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation , 2004, Journal of Medical Genetics.

[34]  Nebojsa Mirkovic,et al.  Structure-Based Assessment of Missense Mutations in Human BRCA1 , 2004, Cancer Research.

[35]  Å. Borg,et al.  One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. , 2004, European journal of cancer.

[36]  N. I. Pospekhova,et al.  Spectrum of Mutations in BRCA1 Gene in Hereditary Forms of Breast and Ovarian Cancer in Russian Families , 2003, Bulletin of Experimental Biology and Medicine.

[37]  J. Garcia-conde,et al.  Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early‐onset breast cancer: Identification of three novel pathogenic mutations , 2003, Human mutation.

[38]  C. Bartram,et al.  Twenty‐three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany , 2003, Human mutation.

[39]  J. Benítez,et al.  Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer , 2002, International journal of cancer.

[40]  M. D'urso,et al.  Characterization of 2 novel and 2 recurring BRCA1 germline mutations in breast and/or ovarian carcinoma patients from the area of Naples. , 2002, International journal of oncology.

[41]  Å. Borg,et al.  BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines , 2002, International journal of cancer.

[42]  P. Pharoah,et al.  BRCA1 and BRCA2 mutations in Russian familial breast cancer , 2002, Human mutation.

[43]  A. Jakubowska,et al.  Founder mutations in the BRCA1 gene in west Belarusian breast‐ovarian cancer families , 2001, Clinical genetics.

[44]  S. Tsuji,et al.  Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  S. Antonarakis,et al.  Nomenclature for the description of human sequence variations , 2001, Human Genetics.

[46]  A. Jakubowska,et al.  Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. , 2000, American journal of human genetics.

[47]  J. Chang-Claude,et al.  A high proportion of mutations in the BRCA1 gene in German breast/ovarian cancer families with clustering of mutations in the 3′ third of the gene , 1998, Human Genetics.

[48]  S. Cummings,et al.  Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  B. Ponder,et al.  Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. , 1997, American journal of human genetics.

[50]  S. Neuhausen,et al.  Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. , 1994, Cancer Research.